Thrivent Financial for Lutherans
RGEN icon

Thrivent Financial for Lutherans’s Repligen RGEN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.1M Buy
425,389
+13,683
+3% +$1.91M 0.1% 265
2025
Q4 		$67.5M Sell
411,706
-47,114
-10% -$7.38M 0.12% 200
2025
Q3 		$61.3M Buy
458,820
+28,716
+7% +$3.49M 0.12% 198
2025
Q2 		$53.5M Sell
430,104
-176,123
-29% -$22.4M 0.12% 213
2025
Q1 		$77.1M Buy
606,227
+1,107
+0.2% +$170K 0.17% 153
2024
Q4 		$87.1M Sell
605,120
-33,482
-5% -$4.8M 0.17% 150
2024
Q3 		$95M Buy
638,602
+36,773
+6% +$5.27M 0.18% 141
2024
Q2 		$75.9M Buy
601,829
+425,061
+240% +$66.6M 0.15% 176
2024
Q1 		$32.5M Sell
176,768
-4,828
-3% -$919K 0.07% 333
2023
Q4 		$32.7M Sell
181,596
-9,998
-5% -$1.56M 0.07% 318
2023
Q3 		$30.5M Buy
191,594
+5,723
+3% +$936K 0.07% 318
2023
Q2 		$26.3M Buy
185,871
+2,783
+2% +$446K 0.06% 365
2023
Q1 		$30.8M Buy
183,088
+5,630
+3% +$1M 0.08% 316
2022
Q4 		$30M Buy
177,458
+2,491
+1% +$452K 0.08% 316
2022
Q3 		$32.7M Sell
174,967
-9,176
-5% -$1.93M 0.09% 268
2022
Q2 		$29.9M Sell
184,143
-41,250
-18% -$6.52M 0.08% 297
2022
Q1 		$42.4M Buy
225,393
+18,828
+9% +$3.58M 0.08% 278
2021
Q4 		$54.7M Buy
206,565
+44,470
+27% +$12M 0.11% 238
2021
Q3 		$46.8M Buy
162,095
+48,805
+43% +$12.5M 0.1% 251
2021
Q2 		$22.6M Buy
113,290
+1,618
+1% +$314K 0.05% 424
2021
Q1 		$21.7M Sell
111,672
-18,828
-14% -$3.86M 0.05% 417
2020
Q4 		$25M Buy
130,500
+16,732
+15% +$3.04M 0.06% 393
2020
Q3 		$16.8M Sell
113,768
-2,709
-2% -$387K 0.04% 445
2020
Q2 		$14.4M Sell
116,477
-10,388
-8% -$1.22M 0.04% 453
2020
Q1 		$12.2M Buy
126,865
+306
+0.2% +$29.5K 0.04% 451
2019
Q4 		$11.7M Buy
126,559
+18,316
+17% +$1.54M 0.03% 527
2019
Q3 		$8.3M Buy
108,243
+64,302
+146% +$5.62M 0.03% 556
2019
Q2 		$3.78M Buy
43,941
+14,149
+47% +$964K 0.01% 752
2019
Q1 		$1.76M Buy
29,792
+2,301
+8% +$132K 0.01% 1032
2018
Q4 		$1.45M Buy
27,491
+1,141
+4% +$66.9K 0.01% 969
2018
Q3 		$1.46M Buy
26,350
+572
+2% +$29.5K ﹤0.01% 1055
2018
Q2 		$1.21M Buy
25,778
+1,403
+6% +$57.7K ﹤0.01% 1141
2018
Q1 		$882K Buy
24,375
+213
+0.9% +$7.49K ﹤0.01% 1306
2017
Q4 		$877K Buy
24,162
+1,320
+6% +$47.8K ﹤0.01% 1333
2017
Q3 		$875K Buy
22,842
+390
+2% +$16.3K ﹤0.01% 1248
2017
Q2 		$930K Buy
22,452
+3,602
+19% +$137K ﹤0.01% 1164
2017
Q1 		$664K Buy
18,850
+780
+4% +$24.7K ﹤0.01% 1388
2016
Q4 		$557K Buy
18,070
+800
+5% +$24.7K ﹤0.01% 1456
2016
Q3 		$521K Buy
17,270
+1,050
+6% +$31.7K ﹤0.01% 1433
2016
Q2 		$444K Buy
16,220
+1,360
+9% +$34.8K ﹤0.01% 1477
2016
Q1 		$399K Buy
14,860
+740
+5% +$18.1K ﹤0.01% 1479
2015
Q4 		$399K Buy
14,120
+220
+2% +$6.34K ﹤0.01% 1451
2015
Q3 		$387K Buy
13,900
+1,900
+16% +$68.7K ﹤0.01% 1333
2015
Q2 		$495K Buy
12,000
+600
+5% +$22K ﹤0.01% 1125
2015
Q1 		$346K Buy
11,400
+100
+0.9% +$2.59K ﹤0.01% 1301
2014
Q4 		$224K Buy
11,300
+100
+0.9% +$2.24K ﹤0.01% 1540
2014
Q3 		$223K Buy
11,200
+100
+0.9% +$2.1K ﹤0.01% 1539
2014
Q2 		$253K Buy
+11,100
New +$198K ﹤0.01% 1495

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Thrivent Financial for Lutherans's RGEN Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Repligen (RGEN) stake by 3.3% in Q1 2026, buying an estimated $1.91M and bringing the position to 425,389 shares worth $50.1M. The position accounts for 0.1% of the portfolio, ranked #265.

Thrivent Financial for Lutherans first reported a position in RGEN in Q2 2014 and has held it in 48 quarters since. The position peaked at $95M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Thrivent Financial for Lutherans held 425,389 shares of Repligen worth $50.1M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 13,683 Repligen shares in Q1 2026, an estimated $1.91M.
  • Repligen made up 0.1% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #265 holding.
  • Thrivent Financial for Lutherans first reported a position in Repligen in Q2 2014 and has held it in 48 quarters since.
  • Thrivent Financial for Lutherans's Repligen position peaked at $95M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.